Correlation of Serum Gamma Glutamyl Transferase and Prostate Specific Antigen Level in Patients with Prostate Disorders
DOI:
https://doi.org/10.51253/pafmj.v75i1.8094Keywords:
Benign prostatic hyperplasia (BPH), Gamma glutamyl transferase, Prostate specific antigen, Prostate density, “American Urological Association” (AUA) score.Abstract
Objective: To correlate gamma-glutamyl transferase, prostate-specific antigen, and prostate-specific antigen density with ultrasound findings, including prostate-specific antigen volume and density, in patients with prostate disorders and to compare differences between Gamma-GT, prostate-specific antigen levels, and density based upon “American Urological Association” score questionnaire groups.
Study Design: Cross sectional study.
Place and Duration of Study: Combined Military Hospital Multan, Pakistan, from Nov 2019 to Dec 2021.
Methodology: We measured prostate indices, including prostate-specific antigen, prostate-specific antigen volume, prostate-specific antigen size, and prostate-specific antigen density, through biochemical measurements and ultrasound examination in a patient population [(n=336) and (age 45-90 years)] randomly after several exclusions that could have affected the results of gamma-glutamyl transferase in known prostate disorders.
Results: Gamma-glutamyl Gamma-glutamyl indices showed a low correlation with prostate-specific antigen levels (p-value= 0.170), ultrasound measures of the prostate gland (p-value=0.088), and derived indices incorporating prostate-specific antigen results (p-value=0.025). PSA showed moderate to higher correlation with Alkaline phosphatase (r=0.422, p<0.001), gamma glutamyl transferase (r=0.170, p=<0.001), PSA volume (r=0.513, p=<0.001), prostate gland size (r=0.520, p=<0.001) and PSA density (r=0.754, p=<0.001). Statistical analysis for various biochemical parameters and PSA measures between groups formulated based on prostate size and the AUA score system was not statistically significant.
Conclusion: Prostate derived ultrasound measures and PSA density showed a higher correlation with PSA. Gamma glutamyl transferase may not help depict prostate gland disease.
Downloads
References
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64(1): 9-29.
https://doi.org/10.3322/caac.21208
Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2018; 319(18): 1914-1931.
https://doi.org/10.1001/jama.2018.3712
Persaud H, Yuan J, Afable A, Bruno DM. Barriers to Prostate Cancer Screening Among Indo-Guyanese. J Community Health 2021; 46(3): 591-596.
https://doi.org/10.1007/s10900-020-00926-5
Daniyal M, Siddiqui ZA, Akram M, Asif HM, Sultana S, Khan A, et al. Epidemiology, etiology, diagnosis and treatment of prostate cancer. Asian Pac J Cancer Prev 2014; 15(22): 9575-9578.
https://doi.org/10.7314/apjcp.2014.15.22.9575
Saad F, Lipton A. Bone-marker levels in patients with prostate cancer: potential correlations with outcomes. CurrOpin Support Palliat Care 2010; 4(3): 127-134.
https://doi.org/10.1097/SPC.0b013e32833ac6d6
Hammerich KH, Donahue TF, Rosner IL, Cullen J, Kuo HC, Hurwitz L, et al. Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer. Urol Oncol 2017; 35(7): 460.e21-460.e28.
https://doi.org/10.1016/j.urolonc.2017.02.001
Chen JT, Kotani K. Serum γ-glutamyl transpeptidase and oxidative stress in subjectively healthy women: an association with menopausal stages. Aging Clin Exp Res 2016; 28(4): 619-24.
https://doi.org/10.1007/s40520-015-0460-y
Drabovich AP, Saraon P, Drabovich M, Karakosta TD, Dimitromanolakis A, Hyndman ME, et al. Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyl transferase 4 in Seminal Plasma of Prostate Cancer Patients. Mol Cell Proteomics 2019 ;18(9): 1807-1823. https://doi.org/10.1074/mcp.RA119.001612
Kunutsor SK, Laukkanen JA. Gamma-glutamyl transferase and risk of prostate cancer: Findings from the KIHD prospective cohort study. Int J Cancer 2017; 140(4): 818-824.
https://doi.org/10.1002/ijc.30511
Bosco C, Garmo H, Hammar N, Walldius G, Jungner I, Malmström H, et al. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort. BMC Cancer 2018; 18(1): 205.
https://doi.org/10.1186/s12885-018-4111-5
Cheung BM, Ong KL, Tso AW, Cherny SS, Sham PC, Lam TH Gamma-glutamyl transferase level predicts the development of hypertension in Hong Kong Chinese. Clin Chim Acta 2011; 412(15-16): 1326-1331.
https://doi.org/10.1016/j.cca.2011.03.030
Ndrepepa G, Colleran R, Kastrati A. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clin Chim Acta 2018; 476: 130-138.
https://doi.org/10.1016/j.cca.2017.11.026
Barry MJ, Fowler FJ Jr, O'leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK; Measurement Committee of the American Urological Association. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 2017; 197(2S): S189-S197.
https://doi.org/10.1016/j.juro.2016.10.071
Nordström T, Akre O, Aly M, Grönberg H, Eklund M. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis 2018; 21(1): 57-63.
https://doi.org/10.1038/s41391-017-0024-7
Arjunlal TS, Deepanjali S, Manikandan R, Medha R. Frequency and clinical significance of prostatic involvement in men with febrile urinary tract infection: a prospective observational study. F1000Res 2020; 9: 617.
https://doi.org/10.12688/f1000research.24094.3
Gui-Zhong L, Libo M, Guanglin H, Jianwei W. The correlation of extent and grade of inflammation with serum PSA levels in patients with IV prostatitis. Int Urol Nephrol 2011; 43(2): 295-301. https://doi.org/10.1007/s11255-010-9825-5
Ross T, Ahmed K, Raison N, Challacombe B, Dasgupta P. Clarifying the PSA grey zone: The management of patients with a borderline PSA. Int J Clin Pract 2016; 70(11): 950-959.
https://doi.org/10.1111/ijcp.12883
Rao SR, Snaith AE, Marino D, Cheng X, Lwin ST, Orriss IR, et al. Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer. Br J Cancer 2017; 116(2): 227-236.
https://doi.org/10.1038/bjc.2016.402
Baba TT, Terashima T, Oida S. Liver-type of tissue non-specific alkaline phosphatase is induced during mouse bone and tooth cell differentiation. Arch Oral Biol 2019; 98: 32-37.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mehreen Aftab Khan, Ayesha Hafeez, Muhammad Younas, Syeda Binte Zahra Rizvi, Waqas Yousaf, Syed Hurr

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.